Sopharma AD (BUL:SFA)

Sopharma AD Balance Sheet

Financials in millions BGN. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	36.07	128.88	19.86	37.72	25.29
Cash & Short-Term Investments	36.07	128.88	19.86	37.72	25.29
Cash Growth	-72.01%	549.10%	-47.37%	49.14%	-8.07%
Accounts Receivable	318.85	279.83	237.35	242.11	257.39
Other Receivables	25.85	16.18	13.07	16.46	20.05
Receivables	356.25	308.75	258.73	260.38	281.45
Inventory	450.67	339.33	278.58	255.95	287.57
Prepaid Expenses	3.27	3.17	2.53	2.7	2.16
Other Current Assets	4.88	6.93	12.8	14.49	15.7
Total Current Assets	851.14	787.06	572.49	571.23	612.18
Property, Plant & Equipment	391.2	357.62	376.41	362.39	395.87
Long-Term Investments	268.5	235.23	167.62	133.1	77.11
Goodwill	5.54	3.44	3.52	13.42	13.27
Other Intangible Assets	253.93	57.83	48.15	54.42	58.27
Long-Term Deferred Tax Assets	3.57	2.82	2.05	1.05	2.05
Other Long-Term Assets	20.42	19.68	19.04	13.36	16.04
Total Assets	1,800	1,514	1,254	1,205	1,242
Accounts Payable	385.46	193.84	153.45	143.64	164.91
Accrued Expenses	33.73	29.7	28.56	24.35	22.27
Short-Term Debt	219.87	200.48	160.23	223.76	291.87
Current Portion of Long-Term Debt	42.97	6.13	9.76	9.47	31.17
Current Portion of Leases	21.59	16.14	15.58	13.31	17.97
Current Income Taxes Payable	3	2.29	1	0.04	1.22
Current Unearned Revenue	4.79	4.41	26.5	2.59	2.34
Other Current Liabilities	14.79	156.2	12.28	6.75	12.7
Total Current Liabilities	726.19	609.19	407.35	423.89	544.45
Long-Term Debt	108.45	56.46	27.76	42.91	34.57
Long-Term Leases	87.38	71.64	69.96	41.18	49.74
Long-Term Unearned Revenue	4.36	4.93	6.16	6.78	10.42
Long-Term Deferred Tax Liabilities	10.44	4.42	6.4	8.47	7.94
Other Long-Term Liabilities	4.85	5.8	13.42	15.58	21.39
Total Liabilities	950.83	760.54	537.34	546.11	675.52
Common Stock	179.1	172.59	134.8	134.8	134.8
Retained Earnings	665.36	590.02	577.25	508.23	421.52
Treasury Stock	-53.56	-57.45	-52.2	-50.28	-33.66
Comprehensive Income & Other	33.02	33.17	44.82	54.23	30.6
Total Common Equity	823.92	738.33	704.66	646.98	553.27
Minority Interest	25.44	15.29	11.98	11.89	13.33
Shareholders' Equity	849.36	753.63	716.63	658.87	566.6
Total Liabilities & Equity	1,800	1,514	1,254	1,205	1,242
Total Debt	480.26	350.85	283.3	330.62	425.33
Net Cash (Debt)	-444.18	-221.97	-263.44	-292.9	-400.04
Net Cash Per Share	-2.70	-1.61	-2.11	-2.34	-3.18
Filing Date Shares Outstanding	165.74	159.11	121.32	121.74	125.79
Total Common Shares Outstanding	165.74	159.11	121.32	121.74	125.79
Working Capital	124.95	177.87	165.15	147.34	67.73
Book Value Per Share	4.97	4.64	5.81	5.31	4.40
Tangible Book Value	564.45	677.06	652.99	579.13	481.73
Tangible Book Value Per Share	3.41	4.26	5.38	4.76	3.83
Land	49.86	51.22	60.25	60.9	60.1
Buildings	326.36	282.35	273.56	244.85	274.58
Machinery	298.16	283.51	279.09	269.77	265.88
Construction In Progress	17.49	7.08	5.51	4.8	10.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.